Details for New Drug Application (NDA): 086113
✉ Email this page to a colleague
NDA 086113 describes GUANETHIDINE MONOSULFATE, which is a drug marketed by Watson Labs and is included in two NDAs. Additional details are available on the GUANETHIDINE MONOSULFATE profile page.
The generic ingredient in GUANETHIDINE MONOSULFATE is guanethidine monosulfate. There are two drug master file entries for this compound. Additional details are available on the guanethidine monosulfate profile page.
The generic ingredient in GUANETHIDINE MONOSULFATE is guanethidine monosulfate. There are two drug master file entries for this compound. Additional details are available on the guanethidine monosulfate profile page.
Summary for 086113
| Tradename: | GUANETHIDINE MONOSULFATE |
| Applicant: | Watson Labs |
| Ingredient: | guanethidine monosulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 086113
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 10MG SULFATE | ||||
| Approval Date: | Mar 26, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
